glp-1 news 2025 october 9 Looming drug patent expirations draw generics firms GLP-1 Receptor Agonist Market Size
Description
How to Use: Mix 4 tsps with 16 ounces of water
Big thanks to our clinical team for this breakthrough innovation
The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status
In contrast, yesterday I moderated a panel at NYULANGONEMEDICALCENTER's "Healthy Communities Symposium" about access and equity in GLP-1RA obesity care
